UKAD 2021 UKAD vs Philip Bowes

Related case:

UKAD 2021 Philip Bowes vs UKAD - Appeal
April 14, 2022

In October 2020 the United Kingdom Anti-Doping (UKAD) has reported an anti-doping rule violation against the boxer Philip Bowes after his A and B samples tested positive for the prohibited substance Ostarine in a low concentration.

After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the National Anti-Doping Panel.

The Athlete gave a prompt admission, denied the intentional use of the substance and requested for a reduced sanction. He asserted that positive test was the result of a contaminated product, yet analysis of his supplements and products he had used revealed no prohibited substances. Supported by expert witnesses he argued that the violation was not intentional and that the analysis of his fingernail and toenail must be allowed by UKAD.

Although the Athlete gave a prompt admission UKAD contended that the Athlete failed to establish that the violation was not intentional, nor the source of the prohibited substance.

The Panel finds that the presence of a prohibited substance has been established in the Athlete's sample and accordingly that he committed an anti-doping rule violation. Further the Panel concludes that the Athlete failed to demonstrate that the violation was not intentional.

Therefore the National Anti-Doping Panel decides on 5 August 2021 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the sample collection, i.e. on 2 September 2020.

Original document

Parameters

Legal Source
National Decisions
Date
5 August 2021
Arbitrator
Crystal, Terry
Gallafent, Kate
Johnson, Lorraine
Original Source
UK Anti-Doping (UKAD)
Country
United Kingdom
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
Case law / jurisprudence
Circumstantial evidence
Prompt / Timely Admission
Sport/IFs
Boxing (IBA) - International Boxing Association
Other organisations
UK Anti-Doping (UKAD)
Analytical aspects
B sample analysis
Doping classes
S1. Anabolic Agents
Substances
Enobosarm (ostarine)
Selective androgen receptor modulators (SARMs)
Various
Supplements
Document type
Pdf file
Date generated
7 June 2022
Date of last modification
14 June 2022
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin